Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig

Acta Biochim Biophys Sin (Shanghai). 2004 Sep;36(9):589-96. doi: 10.1093/abbs/36.9.589.

Abstract

In this study, two DNA fragments encoding amino acid (141-160)-(21-140)-(141-160) of the VP1 of FMDV (foot-and-mouth disease virus) serotype O and (138-160)-(21-40)-(138-160) of the serotype A FMDV were chemically synthesized. These two tandem-repeat fragments were ligated and transfected into prokaryotic expression vector pTrcHis A to construct pTH-O-A. The other vector called pTH-O-scIgG-A was constructed similarly only that the two tandem-repeat DNA fragments were linked by the bovine-IgG heavy chain coding sequence. Guinea pigs immunized with the two bivalent vaccines pTH-O-A and pTH-O-scIgG-A showed both specific antibody activity and T cell proliferation responses. FMDV challenge tests showed that 85% and 70% of guinea pigs vaccinated twice with 200 mg of the fusion protein of pTH-O-A were protected from FMDV serotype O and serotype A infection respectively. 70% and 57% of the guinea pigs immunized with the fusion protein of pTH-O-scIgG-A were protected from FMDV serotype O and serotype A infection respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / biosynthesis
  • Epitopes
  • Foot-and-Mouth Disease / immunology
  • Foot-and-Mouth Disease / prevention & control
  • Foot-and-Mouth Disease Virus / genetics*
  • Foot-and-Mouth Disease Virus / immunology*
  • Guinea Pigs
  • Serotyping*
  • Vaccines, Synthetic / genetics*
  • Vaccines, Synthetic / immunology*
  • Viral Structural Proteins / genetics
  • Viral Structural Proteins / immunology
  • Viral Vaccines / immunology*

Substances

  • Antibodies, Viral
  • Epitopes
  • Vaccines, Synthetic
  • Viral Structural Proteins
  • Viral Vaccines